For citations:

Antsiferov M.B., Galstyan G.R., Demidova T.Yu., Zilov A.V., Markova T.N., Mkrtumyan А.M., Petunina N.A., Khalimov I.S., Shamkhalova M.S., Shestakova M.V. The advisory board resolution on the use of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes. Diabetes mellitus. 2023;26(2):211-214. (In Russ.) https://doi.org/10.14341/DM13034